References
- Jacob MC, Chaperot L, Mossuz P, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003;88: 941–55
- Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: International Agency for Research on Cancer (IARC) Press, 2008;145–7
- Bueno C, Almeida J, Lucio P, et al. Incidence and characteristics of CD4+/HLA DR dendritic cell malignancies. Haematologica 2004;89: 58–69
- Ko YH, Kim SH, Ree HJ. Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation. Histopathology 1998;33: 547–53
- Brody JP, Allen S, Schulman P, et al. Acute agranular CD4-positive natural killer cell leukemia: comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer 1995;75: 2474–83
- Petrella T, Comeau MR, Maynadié M, et al. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26: 852–62
- Herling M, Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 2007;127: 687–700
- Rauh MJ, Rahman F, Good D, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review. Leuk Res 2012;36: 81–6
- Inoue D, Maruyama K, Aoki K, et al. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen. Acta Haematol 2011;126: 122–8
- Zheng G, Schmieg J, Guan H, et al. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings. Acta Cytol 2012;56: 204–8